|
|
Article: Merck & Co., Inc. and NicOx Form Research Collaboration on Nitric Oxide-Donating Drugs.
- Article from:
- PR Newswire
- Article date:
- August 19, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NicOx SA (Nouveau Marche: NICOX) announced today that it has signed a research evaluation agreement with Merck & Co., Inc. to evaluate selected nitric oxide-donating compounds under NicOx's intellectual property rights.
Under the terms of the agreement, NicOx will provide Merck with proprietary nitric oxide-donating compounds for evaluation in a preclinical testing program in an undisclosed therapeutic area. A joint research group will coordinate the research program. The full terms of the collaborative evaluation agreement have not been disclosed.
Merck has the exclusive right for a fixed period of time to license any selected lead compounds identified ...